好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2019 Annual Meeting | C27 - Cerebrovascular Disease II: Update on Guidance-Based Diagnosis and Management of Hemorrhagic Stroke

Saturday 05/04/19
01:30 PM - 03:30 PM EDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Andrew M. Naidech, MD, FAAN
Cerebrovascular Disease and Interventional Neurology
Participants will be able to identify predictors of hematoma expansion and optimal interventions to reverse coagulopathy, and the role of prophylactic seizure medications on outcome after intracerebral hemorrhage.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice
Intermediate
Neurohospitalist, Advanced Practice Provider
General Neurologist, Neurohospitalist
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:30 PM - 02:15 PM EDT Speaker Stauching the Bleeding: Reversing Anticoagulation in Acute ICH
Tiffany Chang, MD
02:15 PM - 03:00 PM EDT Speaker Take the Pressure Off: Blood Pressure Goals in Acute ICH
Alejandro A. Rabinstein, MD, FAAN
03:00 PM - 03:30 PM EDT Speaker Do Not Harm: Balancing Risks and Benefits for Prophylactic Seizure Medications
Steven R. Messe, MD, FAHA, FAAN
Faculty Disclosures
Andrew M. Naidech, MD, FAAN The institution of Dr. Naidech has received research support from NIH. Dr. Naidech has received publishing royalties from a publication relating to health care.
Tiffany Chang, MD Dr. Chang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for National Football League.
Alejandro A. Rabinstein, MD, FAAN Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Steven R. Messe, MD, FAHA, FAAN Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Terumo. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WL Gore. The institution of Dr. Messe has received research support from WL Gore. The institution of Dr. Messe has received research support from Mallinkrodt. The institution of Dr. Messe has received research support from Biogen. Dr. Messe has received intellectual property interests from a discovery or technology relating to health care. Dr. Messe has received publishing royalties from a publication relating to health care. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving as a Clinical Event Committee for the CONFORMAL left atrial appendage occlusion trial with Yale Cardiovascular Research Group.